Skip to main content

Market Overview

Why Grifols Is Trading Higher Today

Why Grifols Is Trading Higher Today

Grifols (NASDAQ: GRFS) shares are trading higher on Thursday. The company announced it's working with the U.S. biomedical advanced research development authority and the FDA to collect plasma from COVID-19 patients.

The plan is to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease.

Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.

Grifols is a Spanish multinational pharmaceutical and chemical manufacturer headquartered in Barcelona. The company is a producer of blood plasma-based products and supplies devices, instruments, and reagents for clinical testing laboratories.

Grifols ADR class B shares were trading up 9.34% at $19.43 on Thursday. The stock has a 52-week range between $25.73 and $13.40.


Related Articles (GRFS)

View Comments and Join the Discussion!

Posted-In: why it's movingBiotech News Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at